Get started
Author

Kalyan Kumar Gangopadhyay

Observed names: Gangopadhyay KK, Gangopadhyay Kalyan K, Gangopadhyay, Kalyan K, Gangopadhyay, Kalyan Kumar, K Gangopadhyay, K K Gangopadhyay, K. Gangopadhyay, K. K. Gangopadhyay, K.K. Gangopadhyay, Kalyan K Gangopadhyay, Kalyan Gangopadhyay, Kalyan K Gangopadhyay, Kalyan K. Gangopadhyay, KalyanK Gangopadhyay
Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Selly Oak Hospital, Birmingham City Hospital, Peerless Hospital & B.K.Roy Research Centre, Fortis Hospital, Fortis Hospital, Medical College and Hospital, Kolkata
ORCID: 0000-0002-3193-977X
Observed ORCID: 0000-0002-3193-977X
OpenAlex ID: A5090262854
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
2020 · Ray Subir, Mukherjee Jagat J, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 71
PDF
Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement
2020 · Rahul Valsaraj, Awadhesh Kumar Singh, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 49
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
2022 · Manoj Chadha, Ashok Kumar Das, et al. · Diabetes Therapy · 48
PDF
The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): A meta-analysis
2020 · S Ghosal, Jagat J Mukherjee, et al. · medRxiv · 32
PDF
Risk of acute pancreatitis with incretin-based therapy: a systematic review and updated meta-analysis of cardiovascular outcomes trials
2020 · Awadhesh Kumar Singh, Kalyan Kumar Gangopadhyay, et al. · Expert Review of Clinical Pharmacology · 32
Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
2019 · Awadhesh Kumar Singh, Ambika G. Unnikrishnan, et al. · Diabetes Therapy · 32
PDF
A Practitioner’s Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel
2020 · Sanjay Kalra, Sarita Bajaj, et al. · Diabetes Therapy · 28
PDF
Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
2020 · Mukherjee Jagat J, Gangopadhyay Kalyan K, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 27
PDF
Assessing prevalence and predictors of depression in Type 2 Diabetes Mellitus (DM) patients – The DEPDIAB study
2021 · Sujoy Majumdar, Binayak Sinha, et al. · Diabetes Research and Clinical Practice · 26
The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysis of observational studies
2023 · Kalyan Kumar Gangopadhyay, Jagat J Mukherjee, et al. · Journal of Radiology and Clinical Imaging · 19
Triggering radiation alarms after radioiodine treatment
2006 · Kalyan Kumar Gangopadhyay, Francis Sundram, et al. · BMJ · 18
PDF
Nontraumatic Rhabdomyolysis: An Unusual Complication of Diabetic Hyperosmolar Nonketotic (HONK) State
2006 · K K Gangopadhyay, R E J Ryder · Journal of the Royal Society of Medicine · 17
PDF
Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
2007 · S. Jessani, K. Gangopadhyay, et al. · International Journal of Clinical Practice · 12
PDF
Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational study
2025 · Ajay Kumar, Anirban Mazumdar, et al. · BMC Nephrology · 11
PDF
Management of diabetes in patients with COVID-19
2020 · Jagat J Mukherjee, Kalyan K Gangopadhyay, et al. · The Lancet Diabetes & Endocrinology · 10
PDF
A case of exclusive dopamine‐secreting paraganglioma
2007 · Kalyan Gangopadhyay, Varadarajan Baskar, et al. · Clinical Endocrinology · 10
Quinary prevention in diabetes care: Need for multidisciplinary approach
2021 · D. Dutta, V. Arora, et al. · Clinical Epidemiology and Global Health · 9
PDF
Consensus evidence-based guidelines for in-patient management of hyperglycaemia in non-critical care setting as per Indian clinical practice.
2014 · Kalyan Kumar Gangopadhyay, Ganapathi Bantwal, et al. · PubMed · 9
Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal
2023 · Kalyan Kumar Gangopadhyay, Awadhesh Kumar Singh · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 8
Insulin glargine versus insulin degludec in patients failing on oral therapy in type 2 diabetes: A retrospective real world comparative data from India
2016 · Samit Ghosal, Binayak Sinha, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 8
Management of Hyperglycemia in Critical Care
2022 · Rajeev Chawla, Kalyan Kumar Gangopadhyay, et al. · Journal of Diabetology · 7
“Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors – A survey"
2020 · Kalyan Kumar Gangopadhyay, Binayak Sinha, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 7
PDF
Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes
2007 · Ateeq Syed, Sania Hussain, et al. · Current Medical Research and Opinion · 7
Capacity and confidence building for general practitioners on optimum insulin use
2019 · Abhay Ahluwalia, Sanjay Kalra, et al. · Journal of Family Medicine and Primary Care · 5
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
2014 · Samit Ghosal, Binayak Sinha, et al. · Diabetes Metabolic Syndrome and Obesity · 5
PDF
Works count: 66
Citation count: 551
H-index: 12
I10-index: 16
Year
Topic
Type